|
1. Chang JW, Tsai HL, Yang LY, Chen TJ. Epidemiology and predictors of end-stage renal disease in Taiwanese children with idiopathic nephrotic syndrome. J Epidemiol 2012; 22(6): 517-22. 2. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 2007; 119(4): e907-e19. 3. Rüth E-M, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 2005; 147(2): 202-7. 4. Ahmadzadeh A, Valavi E, Kamali M, Ahmadzadeh A. Chronic kidney disease in Southwestern Iranian children. Iran J Pediatr 2009; 19(2): 147-53. 5. Banerjee S, Basu S, Sen A, Sengupta J. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2017: 1-8. 6. White RH, Glasgow EF, Mills RJ. Clinicopathologicalstudy of nephrotic syndrome in childhood. Lancet 1970; 1(7661): 1353-9. 7. Ingulli E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 1991; 5(4): 393-7. 8. Kliegman R, Stanton BM, Geme JS, Schor NF. Nelson tratado de pediatría: Elsevier Brasil; 2014. 9. Buckley R, Kliegman R, Stanton B, Geme JS, Schor N, Behrman R. Nelson textbook of pediatrics. 20 ed: Phialdelphia, PA: Elsevier; 2016. 3888 p 10. Gulati S, Godbole M, Singh U, Gulati K, Srivastava A. Are children with idiopathic nephroticyndrome at risk for metabolic bone disease? Am J Kidney Dis 2003; 41(6): 1163-9. 11. Baek HS, Park KS, Kang HG, Ko CW, Cho MH. Initial steroid regimen in idiopathic nephrotic syndrome can be shortened based on duration to first remission. Korean J Pediatr 2015; 58(6): 206-10. 12. Koşan C, Ayar G, Orbak Z. Effects of steroid treatment on bone mineral metabolism in children with Glucocorticoid-sensitive Nephrotic Syndrome. West Indian Med J 2012; 61(6): 627-30. 13. Wojnar J, Roszkowska-Blaim M, Pańczyk-Tomaszewska M. Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D. Przeglad Lekarski 2007; 64(9): 552-8. 14. Polito C, La Manna A, Todisco N, Cimmaruta E, Sessa G, Pirozzi M. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy. Clin Pediatr (Phila) 1995; 34(5): 234-6.
|
.png){kind=logo}
